Showing papers in "Journal of Substance Abuse Treatment in 2020"
••
TL;DR: In the context of the pandemic, buprenorphine prescribers quickly transitioned to providing telemedicine visits in high volume; nonetheless, there are still many unknowns, including the quality and safety of widespread use of telemedICine for OUD treatment.
89 citations
••
TL;DR: It is found that patients who concurrently used methamphetamine were less likely to be retained in buprenorphine treatment compared to non-users, and for persons who were retained, however, methamphetamine use decreased over time.
67 citations
••
TL;DR: In this paper, a brief report draws on experiences from three states' experience with such programs funded by the SAMHSA Opioid State Targeted Repose (STR) grants.
60 citations
••
TL;DR: It is suggested that patients have significant misinformation regarding MouD, including the effects on the type of MOUD prescribed, patient retention and adherence, and ultimately the number of patients treated for OUD, which will aid in curbing the opioid epidemic.
57 citations
••
TL;DR: In this paper, the authors have taken an implementation science approach to expand on the D'Onofrio study by implementing an ED-based buprenorphine initiation program in three diverse South Carolina EDs utilizing a predominantly peer recovery coach model.
51 citations
••
TL;DR: Patients seeking MAT through a clinic that schedules same-day and next-day appointments for treatment are more likely to attend addiction appointments compared to patients who wait longer.
41 citations
••
TL;DR: The many potential future opportunities to leverage the unique national CTN research network to scale-up the science on digital health to examine optimal strategies to increase the reach of science-based SUD service delivery models both within and outside of healthcare are outlined.
34 citations
••
TL;DR: As OUD-related hospitalizations increase, and the opioid-related overdose crisis continues, understanding the constraints related to the development and operations of ACS are important preliminary steps for improving the care of patients hospitalized with OUD.
34 citations
••
TL;DR: Overall, AOD use remained stable over the course of the study, and it may be that connecting urban AI/AN adolescents to culturally centered activities and resources is protective, which has been shown in other work with this population.
32 citations
••
TL;DR: An overview of the steps California is taking to build treatment capacity to address the opioid epidemic highlights the steps to increase the number and capacity of waivered prescribers; enhance skills of prescriber and multidisciplinary teams; and create systems change.
30 citations
••
TL;DR: Modifications to the OUD care continuum included modified supervised injection spaces to adhere to physical distancing, the use of personal protective equipment for overdose response, virtual platforms for clinical encounters, writing longer prescriptions, and providing take-home doses to promote opioid agonist treatment retention.
••
TL;DR: Treatment with BUP-XR monthly injections for up to 12 months in this cohort of treatment-seeking individuals with OUD led to positive PCOs and high treatment satisfaction, which correspond to personal recovery.
••
TL;DR: The majority of PC patients with OUD did not have evidence of treatment with buprenorphine or naltrexone XR, highlighting opportunities for improved identification and treatment in medical settings.
••
TL;DR: This commentary underscores the importance of ensuring a sufficient quantity of methadone take-home doses for patients to maximize their adherence to Methadone maintenance treatment (MMT) during government-imposed lockdown restrictions and social distancing measures designed to curtail the spread of SARS-CoV-2.
••
TL;DR: A pilot study of Project Planned Outreach, Intervention, Naloxone, and Treatment (POINT), the intervention that served as the basis for Indiana's STR-funded, emergency department (ED)-based peer specialist expansion that was conducted in preparation for a larger, multisite pragmatic trial.
••
TL;DR: Though much more work is needed to further reduce logistical, financial, and cultural barriers to improved access to maintenance MOUD, the steps taken through Missouri's STR grant show significant promise at making swift and drastic transformations to a system of care in response to a growing public health emergency.
••
TL;DR: There were few sociodemographic characteristic differences across patients treated at the five hubs, while there were differences in self-reported alcohol and drug use in the 30 days prior to intake.
••
TL;DR: Though many participants personally prefer short-acting to long-acting MOUD, some were open to including long- acting formulations in the range of options for those with OUD, suggesting support for expanded access to a variety of formulations of MouD.
••
TL;DR: Polysubstance use is common in hospitalized patients with substance use disorders and identifying patterns of polysubStance use can guide clinical management, and hospital providers should prepare to manage polysubstances use during hospitalization and hospitals should broaden care beyond interventions for opioid use disorder.
••
TL;DR: The Washington State Hub and Spoke Model built on prior approaches to improve the delivery system for OUD medication treatment and support services, by increasing integration of care, ensuring "no wrong door," engaging with community agencies, and supporting providers who are offering medication treatment.
••
TL;DR: The preliminary results suggest that assertive outreach could be a promising strategy to motivate people to enter and remain in long-term treatment.
••
TL;DR: Primary care organizations likely need service models, technologies, and workforces, including non-physician behavioral health specialists, to improve capacities to diagnose and treat AUD and OUD.
••
TL;DR: Patterns of reductions in alcohol demand indices, delay discounting rates, and an increase in mindfulness after both acute (1 session) and extended (4 sessions) exposure to EFT are observed.
••
TL;DR: The evidence suggests that a variety of psychological treatments are effective in reducing levels of methamphetamine use and improving psychiatric symptoms, and future research should consider how psychological treatments could maximize outcomes in the co-occurring domains of methamphetamine Use and psychiatric symptoms.
••
TL;DR: The increasing prevalence of opioid use disorders among pregnant and postpartum women (PPW) has generated a need for greater availability of specialized programs offering evidence-based and comprehensive substance use disorder treatment services tailored to this population, and recent time trends and the geographic distribution of treatment facilities with specialized programs are described.
••
TL;DR: The results indicate the potential for LAI-PrEP, as an alternative to oral daily PrEP, to be implemented into existing evidence- based HIV-based HIV prevention efforts that target high-risk PWUD.
••
TL;DR: Preliminary results provide initial support for targeting behavioral economic mechanisms of change in an outpatient AUD treatment with a single-session intervention plus remote delivery of booster prompts.
••
TL;DR: Receipt of BI for unhealthy alcohol use varied by race/ethnicity and gender, and the impact of one factor depended on the other, suggesting that reducing disparities in alcohol-related care may require targeted interventions.
••
TL;DR: It is demonstrated that the peer outreach and treatment linkage intervention may be successfully used to engage individuals with OUD into treatment.
••
TL;DR: There is a layered effect of increasing co-occurring SUDs leading to worse hospitalization outcomes, and the heterogeneity of drug use patterns needs to be considered when developing strategies to improve health care outcomes for people with substance use disorder.